The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities. During this session we will provide an overall introduction to the 340B program and discuss key compliance and self-audit considerations. We will also address the management of contract pharmacy arrangements, 340B program administrators, and Health Center strategies related to manufacturer restrictions.
Change in anything is often met with trepidation but change often brings opportunities. During this session we will review the fundamentals of value based care and how it compares to the current reimbursement environment for FQHC’s…
Health centers need to have positive bottom lines to fund growth and development. This session will show the link between budgeting and profitability and identify key drivers of the health center’s bottom line…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.